Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor
Read Me

Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
Read Me

Pear Therapeutics Announces $50 Million Credit Facility From Perceptive Advisors
Read Me

Vor Biopharma Closes $110 Million Series B Financing
Read Me

scPharmaceuticals Announces FUROSCIX® NDA Resubmission

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA